EXPE vs NEPH · P/E 20, rev $13.69B vs P/E 48, rev $14.2M
Expedia Group Inc. (EXPE) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the EXPE and NEPH stock pages for the full models.
Not investment advice.